Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Careers and Recruitment
  • Published:

As life sciences sector's positive momentum continues, so do executive compensation levels

Nature Biotechnology volume 36, pages 661–664 (2018)Cite this article

Non-founder total target cash compensation in 2017 increased 8.3% year-over-year at private life sciences companies and 6.4% at private technology companies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3: Screenshot of a sample CompStudy target severance histogram from the 2017 survey.

References

  1. Rychlik, B. Nat. Biotechnol. 35, 383–386 (2017).

    Article  CAS  Google Scholar 

  2. Rychlik, B. Nat. Biotechnol. 34, 667–670 (2016).

    Article  CAS  Google Scholar 

  3. Wasserman, N. The Founder's Dilemmas: Anticipating and Avoiding the Pitfalls That Can Sink a Startup (Princeton University Press, 2012).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bruce Rychlik is at Park Square Executive Search, Boston, Massachusetts, USA.,

    Bruce Rychlik

Authors
  1. Bruce Rychlik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce Rychlik.

Ethics declarations

Competing interests

The author declares competing interests. Cognition Therapeutics is a former client of Park Square Executive Research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rychlik, B. As life sciences sector's positive momentum continues, so do executive compensation levels. Nat Biotechnol 36, 661–664 (2018). https://doi.org/10.1038/nbt.4188

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.4188

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing